GenomeQuest's DrugBank Pro database provides a central location for scientists, chemists and pharmaceutical researchers to search sequence and annotation information on all drugs, targets and their metabolizing enzymes. Through an exclusive relationship with the University of Alberta, GenomeQuest provides this information to its customers, 6 months ahead of release on the public DrugBank website.
Locating information on drugs in clinical trials is difficult at best, and is highly relevant for target exploration, competitive intelligence efforts and more. DrugBank Pro provides exclusive access ( this information is never released on the public DrugBank website) to pharmacological information on drugs undergoing clinical trials. DrugBank Pro users can access cutting edge pharmacology information on investigational drugs as easily as they can on approved drugs.
DrugBank Pro alleviates the burden of having to scour multiple online resources and provides a central data source for queries like:
DrugBank Pro has a complete update of all drugs and their status, every 6 months and is offered as a select-access database.

White Paper
Bioinformatics for High Throughput Sequence Search and Analysis